551 related articles for article (PubMed ID: 32474220)
1. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion.
Hayashi M; Sahashi Y; Baba Y; Okura H; Shimohata T
J Neurol Sci; 2020 Aug; 415():116941. PubMed ID: 32474220
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated Leukoencephalopathy.
Sachs JR; Gibbs KW; Swor DE; Sweeney AP; Williams DW; Burdette JH; West TG; Geer CP
Radiology; 2020 Sep; 296(3):E184-E185. PubMed ID: 32407258
[No Abstract] [Full Text] [Related]
3. A Recurrent Mild Encephalitis/Encephalopathy with Reversible Splenial Lesion.
Xia C
Neurol India; 2023; 71(3):602-603. PubMed ID: 37322781
[No Abstract] [Full Text] [Related]
4. COVID-19-associated Diffuse Leukoencephalopathy and Microhemorrhages.
Radmanesh A; Derman A; Lui YW; Raz E; Loh JP; Hagiwara M; Borja MJ; Zan E; Fatterpekar GM
Radiology; 2020 Oct; 297(1):E223-E227. PubMed ID: 32437314
[TBL] [Abstract][Full Text] [Related]
5. Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review.
Yuan J; Yang S; Wang S; Qin W; Yang L; Hu W
BMC Neurol; 2017 May; 17(1):103. PubMed ID: 28545419
[TBL] [Abstract][Full Text] [Related]
6. Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection.
Kandemirli SG; Dogan L; Sarikaya ZT; Kara S; Akinci C; Kaya D; Kaya Y; Yildirim D; Tuzuner F; Yildirim MS; Ozluk E; Gucyetmez B; Karaarslan E; Koyluoglu I; Demirel Kaya HS; Mammadov O; Kisa Ozdemir I; Afsar N; Citci Yalcinkaya B; Rasimoglu S; Guduk DE; Kedir Jima A; Ilksoz A; Ersoz V; Yonca Eren M; Celtik N; Arslan S; Korkmazer B; Dincer SS; Gulek E; Dikmen I; Yazici M; Unsal S; Ljama T; Demirel I; Ayyildiz A; Kesimci I; Bolsoy Deveci S; Tutuncu M; Kizilkilic O; Telci L; Zengin R; Dincer A; Akinci IO; Kocer N
Radiology; 2020 Oct; 297(1):E232-E235. PubMed ID: 32384020
[No Abstract] [Full Text] [Related]
7. COVID-19-Associated Cytotoxic Lesions of the Corpus Callosum.
Gaur P; Dixon L; Jones B; Lyall H; Jan W
AJNR Am J Neuroradiol; 2020 Oct; 41(10):1905-1907. PubMed ID: 32819904
[TBL] [Abstract][Full Text] [Related]
8. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).
Takanashi J; Imamura A; Hayakawa F; Terada H
J Neurol Sci; 2010 May; 292(1-2):24-7. PubMed ID: 20236662
[TBL] [Abstract][Full Text] [Related]
9. Mild encephalitis/encephalopathy with a reversible splenial lesion: five cases and a literature review.
Pan JJ; Zhao YY; Lu C; Hu YH; Yang Y
Neurol Sci; 2015 Nov; 36(11):2043-51. PubMed ID: 26130145
[TBL] [Abstract][Full Text] [Related]
10. Mild encephalopathy with reversible splenium lesion (MERS) in a patient with COVID-19.
Kakadia B; Ahmed J; Siegal T; Jovin TG; Thon JM
J Clin Neurosci; 2020 Sep; 79():272-274. PubMed ID: 33070911
[TBL] [Abstract][Full Text] [Related]
11. Multifocal laminar cortical brain lesions: a consistent MRI finding in neuro-COVID-19 patients.
Anzalone N; Castellano A; Scotti R; Scandroglio AM; Filippi M; Ciceri F; Tresoldi M; Falini A
J Neurol; 2020 Oct; 267(10):2806-2809. PubMed ID: 32506390
[No Abstract] [Full Text] [Related]
12. Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Coincidents with Bickerstaff Brainstem Encephalitis.
Shimada T; Sano M; Tsunemi T; Hattori N
Neurol India; 2022; 70(4):1746-1747. PubMed ID: 36076717
[No Abstract] [Full Text] [Related]
13. Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient With COVID-19.
Trellu LT; Kaya G; Alberto C; Calame A; McKee T; Calmy A
JAMA Dermatol; 2020 Aug; 156(8):922-924. PubMed ID: 32579185
[No Abstract] [Full Text] [Related]
14. Mild encephalitis/encephalopathy with a reversible splenial lesion associated with systemic Mycoplasma pneumoniae infection in North America: a case report.
Talukder NT; Feezel A; Lankford JE
J Med Case Rep; 2022 Feb; 16(1):74. PubMed ID: 35183255
[TBL] [Abstract][Full Text] [Related]
15. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient.
Princiotta Cariddi L; Tabaee Damavandi P; Carimati F; Banfi P; Clemenzi A; Marelli M; Giorgianni A; Vinacci G; Mauri M; Versino M
J Neurol; 2020 Nov; 267(11):3157-3160. PubMed ID: 32583053
[TBL] [Abstract][Full Text] [Related]
16. Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2).
Paolino G; Canti V; Mercuri SR; Rovere Querini P; Candiani M; Pasi F
Int J Dermatol; 2020 Jul; 59(7):874-875. PubMed ID: 32358979
[No Abstract] [Full Text] [Related]
17. Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow.
Ackermann M; Mentzer SJ; Kolb M; Jonigk D
Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 33008942
[TBL] [Abstract][Full Text] [Related]
18. [Syndrome of mild encephalopathy with a reversible splenial corpus callosum lesion].
Titov AV; Novicova VS; Ochkin SS; Soloveva EY
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):85-87. PubMed ID: 29376989
[TBL] [Abstract][Full Text] [Related]
19. First ultrastructural autoptic findings of SARS -Cov-2 in olfactory pathways and brainstem.
Bulfamante G; Chiumello D; Canevini MP; Priori A; Mazzanti M; Centanni S; Felisati G
Minerva Anestesiol; 2020 Jun; 86(6):678-679. PubMed ID: 32401000
[No Abstract] [Full Text] [Related]
20. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).
Fernández-Domínguez J; Ameijide-Sanluis E; García-Cabo C; García-Rodríguez R; Mateos V
J Neurol; 2020 Sep; 267(9):2495-2496. PubMed ID: 32458195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
